Synergy Disc® presentation showcased statistically superior IDE trial outcomes, restoration of cervical lordosis, and long-term motion preservation in complex cervical...
Presentation explored motion-restoring alternatives for select patients with persistent pain or pseudoarthrosis following cervical fusion surgery BEVERLY HILLS, CA /...
WHO identifies rVSV-based candidate as a top priority amid growing Ebola epidemic with no approved countermeasuresKey points:WHO urges development of...
Company highlights streamlined body-map tracking and image management features designed to support long-term skin monitoring workflows MESA, AZ / ACCESS...
London, United Kingdom--(Newsfile Corp. - June 1, 2026) - Edison issues report on Nabaltec (XETRA: NTG).Nabaltec is a German specialist...
SAN DIEGO, CA / ACCESS Newswire / June 1, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a...
SAN DIEGO, CA / ACCESS Newswire / June 1, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a...
NORTHAMPTON, MA / ACCESS Newswire / June 1, 2026 / Originally published on CVS Health Company NewsroomKey pointsMany older adults...
NORTHAMPTON, MA / ACCESS Newswire / June 1, 2026 / Originally published on CVS Health Company NewsroomKey pointsMany older adults...
Pesticides. Mycotoxins. Fraudulent Lab Reports. Forged Certificates of Analysis. This Is the State-Licensed Cannabis and Hemp Supply Chain the Courts...
Pesticides. Mycotoxins. Fraudulent Lab Reports. Forged Certificates of Analysis. This Is the State-Licensed Cannabis and Hemp Supply Chain the Courts...
At a median 5-year (60.3 months) planned follow-up of the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, intismeran autogene in combination with KEYTRUDA...
At a median 5-year (60.3 months) planned follow-up of the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, intismeran autogene in combination with KEYTRUDA...
FORT LAUDERDALE, FL / ACCESS Newswire / June 1, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical...
FORT LAUDERDALE, FL / ACCESS Newswire / June 1, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical...
Independent qualitative KPIs across 48 RCM categories will help healthcare buyers prove platform performance before purchase, measuring user experience, functional...
Independent qualitative KPIs across 48 RCM categories will help healthcare buyers prove platform performance before purchase, measuring user experience, functional...
Focus is on closing DelivMeds AI transaction, driving pharmacy revenue growth and supporting PharmacyChain™, Medical Drones and Health Lives Here...
Focus is on closing DelivMeds AI transaction, driving pharmacy revenue growth and supporting PharmacyChain™, Medical Drones and Health Lives Here...
NEWARK, CA / ACCESS Newswire / June 1, 2026 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced that...